KRT20 and bladder transitional cell carcinoma: Bladder cancer 4 (BLCA-4), minichromosomal maintenance 5 (MCM5), human telomerase reverse transcriptase (hTERT), circulating tumor cells (CTCs), and cytokeratin 20 (CK-20) have been reported to be biomarkers of urothelial carcinoma.